Dermatology NewsTNF blocker safety may differ in RA and psoriasis patientsJune 14, 2016PsoriasisPsoriatic Arthritis
Dermatology NewsFull resolution of psoriasis in half of ixekizumab patientsJune 14, 2016PsoriasisPsoriatic Arthritis
Dermatology NewsSerious infections are increasing among psoriasis inpatientsMay 16, 2016PsoriasisInfectious DiseasesPsoriatic Arthritis
Dermatology NewsBrodalumab effective for rare, severe types of psoriasisMay 6, 2016Psoriatic ArthritisPsoriasisRare Diseases
Dermatology NewsEffective psoriasis therapy may reduce coronary plaque burdenApril 28, 2016PsoriasisPsoriatic Arthritis
Dermatology NewsPsoriasis tied to abdominal aortic aneurysm in nationwide studyApril 14, 2016PsoriasisPsoriatic Arthritis
Dermatology NewsInflectra becomes first FDA-approved biosimilar for inflammatory diseasesApril 5, 2016Psoriatic ArthritisPsoriasis
Dermatology NewsSparse, poor evidence supports fumarates for psoriasisMarch 15, 2016PsoriasisPsoriatic Arthritis
Dermatology NewsFresh evidence of methotrexate efficacy in psoriatic arthritisMarch 13, 2016Psoriatic ArthritisPsoriasis
Dermatology NewsDon’t overlook topical tazarotene for psoriasisMarch 10, 2016PsoriasisPsoriatic Arthritis
Dermatology News60 weeks of ixekizumab effective, well tolerated in moderate-to-severe plaque psoriasisMarch 10, 2016PsoriasisPsoriatic Arthritis
